ASA

This brand name is authorized in Canada, Ecuador, Finland, Mexico.

Active ingredients

The drug ASA contains one active pharmaceutical ingredient (API):

1	Acetylsalicylic acid UNII R16CO5Y76E - ASPIRIN
	Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.
	Read more about Acetylsalicylic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ASA Delayed-release tablet	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC06	Acetylsalicylic acid	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC06
N02BA01	Acetylsalicylic acid	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives
Discover more medicines within N02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00530336, 02244993, 02270323, 02372177, 02394790, 02426811, 02433044, 02449277, 02497115
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	02867-MAE-11-03, 02889-MAC-11-03
FI	Lääkealan turvallisuus- ja kehittämiskeskus	025013, 025024
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	75094